[HTML][HTML] Multifunctional natural killer cell engagers targeting NKp46 trigger protective tumor immunity
L Gauthier, A Morel, N Anceriz, B Rossi… - Cell, 2019 - cell.com
Over the last decade, various new therapies have been developed to promote anti-tumor
immunity. Despite interesting clinical results in hematological malignancies, the …
immunity. Despite interesting clinical results in hematological malignancies, the …
[引用][C] Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
L Gauthier, A Morel, N Anceriz, B Rossi… - Cell, 2019 - cir.nii.ac.jp
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor
Immunity | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Immunity | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
[PDF][PDF] Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
L Gauthier, A Morel, N Anceriz, B Rossi… - Cell, 2019 - fenix.ciencias.ulisboa.pt
Over the last decade, various new therapies have been developed to promote anti-tumor
immunity. Despite interesting clinical results in hematological malignancies, the …
immunity. Despite interesting clinical results in hematological malignancies, the …
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
L Gauthier, A Morel, N Anceriz, B Rossi… - Cell, 2019 - pubmed.ncbi.nlm.nih.gov
Over the last decade, various new therapies have been developed to promote anti-tumor
immunity. Despite interesting clinical results in hematological malignancies, the …
immunity. Despite interesting clinical results in hematological malignancies, the …
[PDF][PDF] Multifunctional natural killer cell engagers targeting NKp46 trigger protective tumor immunity
L Gauthier, A Morel, N Anceriz, B Rossi… - innate-pharma.com
Présentation PowerPoint Page 1 SITC 2019 innate pharma S p e c ific ly s is (% ) D1 D2 50
101 10-1 100 0 10-3 10-5 NKp46-1/Fc/CD20-F5 NKp46-1/(Fc)/CD20-F6 IC/Fc/CD20-F5 …
101 10-1 100 0 10-3 10-5 NKp46-1/Fc/CD20-F5 NKp46-1/(Fc)/CD20-F6 IC/Fc/CD20-F5 …
[HTML][HTML] Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
L Gauthier, A Morel, N Anceriz, B Rossi… - Cell, 2019 - Elsevier
Over the last decade, various new therapies have been developed to promote anti-tumor
immunity. Despite interesting clinical results in hematological malignancies, the …
immunity. Despite interesting clinical results in hematological malignancies, the …
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity.
L Gauthier, A Morel, N Anceriz, B Rossi… - Cell, 2019 - europepmc.org
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity.
- Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
- Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
L Gauthier, A Morel, N Anceriz, B Rossi… - Cell, 2019 - hal.science
Over the last decade, various new therapies have been developed to promote anti-tumor
immunity. Despite interesting clinical results in hematological malignancies, the …
immunity. Despite interesting clinical results in hematological malignancies, the …
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
L Gauthier, A Morel, N Anceriz, Y Morel… - paper.sciencenet.cn
Over the last decade, various new therapies have been developed to promote anti-tumor
immunity. Despite interesting clinical results in hematological malignancies, the …
immunity. Despite interesting clinical results in hematological malignancies, the …
[PDF][PDF] Multifunctional natural killer cell engagers targeting NKp46 trigger protective tumor immunity
L Gauthier, A Morel, N Anceriz, B Rossi… - innate-pharma.com
Présentation PowerPoint Page 1 SITC 2019 innate pharma S p e c ific ly s is (% ) D1 D2 50
101 10-1 100 0 10-3 10-5 NKp46-1/Fc/CD20-F5 NKp46-1/(Fc)/CD20-F6 IC/Fc/CD20-F5 …
101 10-1 100 0 10-3 10-5 NKp46-1/Fc/CD20-F5 NKp46-1/(Fc)/CD20-F6 IC/Fc/CD20-F5 …